EIT Health welcomes the Commissions Biotech Act proposal to boost European competitiveness & innovation, via the biotech sector. The key drivers outlined by the Commission are explored in a recent EIT Health Think Tank report, Skills, scale and science: Uniting European Innovation Ecosystems through the Biotech Act, by industry experts.
EIT Health
Other · Germany · EU Transparency Register 781385241347-65not in register snapshot
This register number is the organization’s own declaration on its submission. It is not in the 30 Aug 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track EIT in PolicySpeak: request access →
Work at EIT Health? so we know who speaks for it.
Their record over time
EIT Health filed 2 positions between 11 Jun 2025 and 26 Mar 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 2 times.
What they argued
EIT Health welcomes the commitment to reinforce Europes competitiveness through the Biotech Act. The European biotech sector has the potential to transform health outcomes, strengthen Europes strategic autonomy, and drive competitiveness. Small start-ups and SMEs require specific policy support and are disproportionately impacted by a number of issues.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from EIT Health’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.